310142 VO DNA-Tumor Viruses, from Cancer Agent to therapy (2006S)
DNA-Tumor Viruses, from Cancer Agent to therapy (Elective Course in Molecular Medicine)
Labels
BZB/Ebene 2, 1030, Dr. Bohr-Gasse 9
Department für Med.Biochemie der Med.Uni.Wien
Auch für Dissertant/Innen geeignet
Department für Med.Biochemie der Med.Uni.Wien
Auch für Dissertant/Innen geeignet
Details
Language: German
Lecturers
Classes
Currently no class schedule is known.
Information
Aims, contents and method of the course
Assessment and permitted materials
Minimum requirements and assessment criteria
Examination topics
Reading list
Association in the course directory
M210, M400
Last modified: Fr 31.08.2018 08:57
DNA tumour viruses play not only an import role as human pathogens causing diseases like cervical cancer but also serve as important tools to elucidate basic mechanisms of cancerogenesis. For example, the tumour suppressor protein p53 was discovered as a cellular protein of 53kDa targeted and inactivated by the large tumour antigen (LT) of the DNA tumour virus SV40. More recently, a novel anti-cancer strategy was developed based on the lytic function of DNA tumour viruses (e.g. ONYX015).
The lecture will include the following topics:
Classification of DNA tumour viruses
Lytic and transformation cycle
Viral oncoproteins and their cellular targets: p53, pRB (the retinoblastoma gene product), protein phosphatase 2A (PP2A) and others
Human Papillomavirus and the development of cervical carcinoma
Cancer therapy with adenovirus mutants